Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators

Background and objectives: The Dutch healthcare system is in transition towards managed competition. In theory, a system of managed competition involves incentives for quality and efficiency of provided care. This is mainly because health insurers contract on behalf of their clients with healthcare...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Portrait, France R. M [verfasserIn] Galiën, Onno Van den Berg, Bernard

Format:	Artikel
Sprache:	Englisch

Erschienen:	2016

Rechteinformationen:	Nutzungsrecht: Copyright © 2015 John Wiley & Sons, Ltd.

Schlagwörter:	integrated care health system reform diabetes mellitus type 2 managed competition healthcare providers' performance multidimensional quality costs Competition Health care industry Quality of care

Übergeordnetes Werk:	Enthalten in: Health economics - Chichester : Wiley-Blackwell, 1992, 25(2016), 4, Seite 408-423
Übergeordnetes Werk:	volume:25 ; year:2016 ; number:4 ; pages:408-423

Links:	Volltext Link aufrufen Link aufrufen Link aufrufen

DOI / URN:	10.1002/hec.3158

Katalog-ID:	OLC1975922794

Internformat


LEADER	01000caa a2200265 4500
001	OLC1975922794
003	DE-627
005	20230714193153.0
007	tu
008	160609s2016 xx \|\|\|\|\| 00\| \|\|eng c
024	7		\|a 10.1002/hec.3158 \|2 doi
028	5	2	\|a PQ20160610
035			\|a (DE-627)OLC1975922794
035			\|a (DE-599)GBVOLC1975922794
035			\|a (PRQ)p1788-fb911c77b6a1f3707a250c06ad7cbe1c68180c7da9eda1b68900afa50a83266c3
035			\|a (KEY)0214778520160000025000400408measuringhealthcareprovidersperformanceswithinmana
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 610 \|q ZDB
100	1		\|a Portrait, France R. M \|e verfasserin \|4 aut
245	1	0	\|a Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators
264		1	\|c 2016
336			\|a Text \|b txt \|2 rdacontent
337			\|a ohne Hilfsmittel zu benutzen \|b n \|2 rdamedia
338			\|a Band \|b nc \|2 rdacarrier
520			\|a Background and objectives: The Dutch healthcare system is in transition towards managed competition. In theory, a system of managed competition involves incentives for quality and efficiency of provided care. This is mainly because health insurers contract on behalf of their clients with healthcare providers on, potentially, quality and costs. The paper develops a strategy to comprehensively analyse available multidimensional data on quality and costs to assess and report on the relative performance of healthcare providers within managed competition. Data and methods: We had access to individual information on 2409 clients of 19 Dutch diabetes care groups on a broad range of (outcome and process related) quality and cost indicators. We carried out a cost‐consequences analysis and corrected for differences in case mix to reduce incentives for risk selection by healthcare providers. Results and conclusion: There is substantial heterogeneity between diabetes care groups' performances as measured using multidimensional indicators on quality and costs. Better quality diabetes care can be achieved with lower or higher costs. Routine monitoring using multidimensional data on quality and costs merged at the individual level would allow a systematic and comprehensive analysis of healthcare providers' performances within managed competition. Copyright © 2015 John Wiley & Sons, Ltd.
540			\|a Nutzungsrecht: Copyright © 2015 John Wiley & Sons, Ltd.
650		4	\|a integrated care
650		4	\|a health system reform
650		4	\|a diabetes mellitus type 2
650		4	\|a managed competition
650		4	\|a healthcare providers' performance
650		4	\|a multidimensional quality
650		4	\|a costs
650		4	\|a Competition
650		4	\|a Health care industry
650		4	\|a Quality of care
700	1		\|a Galiën, Onno \|4 oth
700	1		\|a Van den Berg, Bernard \|4 oth
773	0	8	\|i Enthalten in \|t Health economics \|d Chichester : Wiley-Blackwell, 1992 \|g 25(2016), 4, Seite 408-423 \|w (DE-627)170982289 \|w (DE-600)1135838-5 \|w (DE-576)052841952 \|x 1057-9230 \|7 nnns
773	1	8	\|g volume:25 \|g year:2016 \|g number:4 \|g pages:408-423
856	4	1	\|u http://dx.doi.org/10.1002/hec.3158 \|3 Volltext
856	4	2	\|u http://onlinelibrary.wiley.com/doi/10.1002/hec.3158/abstract
856	4	2	\|u http://www.ncbi.nlm.nih.gov/pubmed/25702821
856	4	2	\|u http://search.proquest.com/docview/1769330678
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a SSG-OLC-WIW
912			\|a SSG-OLC-PHA
912			\|a SSG-OLC-DE-84
912			\|a GBV_ILN_26
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4219
951			\|a AR
952			\|d 25 \|j 2016 \|e 4 \|h 408-423

Indexfelder

author_variant	f r m p frm frmp
matchkey_str	article:10579230:2016----::esrnhatcrpoiesefracsihnaaecmeiinsnmliies
hierarchy_sort_str	2016
publishDate	2016
allfields	10.1002/hec.3158 doi PQ20160610 (DE-627)OLC1975922794 (DE-599)GBVOLC1975922794 (PRQ)p1788-fb911c77b6a1f3707a250c06ad7cbe1c68180c7da9eda1b68900afa50a83266c3 (KEY)0214778520160000025000400408measuringhealthcareprovidersperformanceswithinmana DE-627 ger DE-627 rakwb eng 610 ZDB Portrait, France R. M verfasserin aut Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators 2016 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Background and objectives: The Dutch healthcare system is in transition towards managed competition. In theory, a system of managed competition involves incentives for quality and efficiency of provided care. This is mainly because health insurers contract on behalf of their clients with healthcare providers on, potentially, quality and costs. The paper develops a strategy to comprehensively analyse available multidimensional data on quality and costs to assess and report on the relative performance of healthcare providers within managed competition. Data and methods: We had access to individual information on 2409 clients of 19 Dutch diabetes care groups on a broad range of (outcome and process related) quality and cost indicators. We carried out a cost‐consequences analysis and corrected for differences in case mix to reduce incentives for risk selection by healthcare providers. Results and conclusion: There is substantial heterogeneity between diabetes care groups' performances as measured using multidimensional indicators on quality and costs. Better quality diabetes care can be achieved with lower or higher costs. Routine monitoring using multidimensional data on quality and costs merged at the individual level would allow a systematic and comprehensive analysis of healthcare providers' performances within managed competition. Copyright © 2015 John Wiley & Sons, Ltd. Nutzungsrecht: Copyright © 2015 John Wiley & Sons, Ltd. integrated care health system reform diabetes mellitus type 2 managed competition healthcare providers' performance multidimensional quality costs Competition Health care industry Quality of care Galiën, Onno oth Van den Berg, Bernard oth Enthalten in Health economics Chichester : Wiley-Blackwell, 1992 25(2016), 4, Seite 408-423 (DE-627)170982289 (DE-600)1135838-5 (DE-576)052841952 1057-9230 nnns volume:25 year:2016 number:4 pages:408-423 http://dx.doi.org/10.1002/hec.3158 Volltext http://onlinelibrary.wiley.com/doi/10.1002/hec.3158/abstract http://www.ncbi.nlm.nih.gov/pubmed/25702821 http://search.proquest.com/docview/1769330678 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-WIW SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_26 GBV_ILN_4012 GBV_ILN_4126 GBV_ILN_4219 AR 25 2016 4 408-423
spelling	10.1002/hec.3158 doi PQ20160610 (DE-627)OLC1975922794 (DE-599)GBVOLC1975922794 (PRQ)p1788-fb911c77b6a1f3707a250c06ad7cbe1c68180c7da9eda1b68900afa50a83266c3 (KEY)0214778520160000025000400408measuringhealthcareprovidersperformanceswithinmana DE-627 ger DE-627 rakwb eng 610 ZDB Portrait, France R. M verfasserin aut Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators 2016 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Background and objectives: The Dutch healthcare system is in transition towards managed competition. In theory, a system of managed competition involves incentives for quality and efficiency of provided care. This is mainly because health insurers contract on behalf of their clients with healthcare providers on, potentially, quality and costs. The paper develops a strategy to comprehensively analyse available multidimensional data on quality and costs to assess and report on the relative performance of healthcare providers within managed competition. Data and methods: We had access to individual information on 2409 clients of 19 Dutch diabetes care groups on a broad range of (outcome and process related) quality and cost indicators. We carried out a cost‐consequences analysis and corrected for differences in case mix to reduce incentives for risk selection by healthcare providers. Results and conclusion: There is substantial heterogeneity between diabetes care groups' performances as measured using multidimensional indicators on quality and costs. Better quality diabetes care can be achieved with lower or higher costs. Routine monitoring using multidimensional data on quality and costs merged at the individual level would allow a systematic and comprehensive analysis of healthcare providers' performances within managed competition. Copyright © 2015 John Wiley & Sons, Ltd. Nutzungsrecht: Copyright © 2015 John Wiley & Sons, Ltd. integrated care health system reform diabetes mellitus type 2 managed competition healthcare providers' performance multidimensional quality costs Competition Health care industry Quality of care Galiën, Onno oth Van den Berg, Bernard oth Enthalten in Health economics Chichester : Wiley-Blackwell, 1992 25(2016), 4, Seite 408-423 (DE-627)170982289 (DE-600)1135838-5 (DE-576)052841952 1057-9230 nnns volume:25 year:2016 number:4 pages:408-423 http://dx.doi.org/10.1002/hec.3158 Volltext http://onlinelibrary.wiley.com/doi/10.1002/hec.3158/abstract http://www.ncbi.nlm.nih.gov/pubmed/25702821 http://search.proquest.com/docview/1769330678 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-WIW SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_26 GBV_ILN_4012 GBV_ILN_4126 GBV_ILN_4219 AR 25 2016 4 408-423
allfields_unstemmed	10.1002/hec.3158 doi PQ20160610 (DE-627)OLC1975922794 (DE-599)GBVOLC1975922794 (PRQ)p1788-fb911c77b6a1f3707a250c06ad7cbe1c68180c7da9eda1b68900afa50a83266c3 (KEY)0214778520160000025000400408measuringhealthcareprovidersperformanceswithinmana DE-627 ger DE-627 rakwb eng 610 ZDB Portrait, France R. M verfasserin aut Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators 2016 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Background and objectives: The Dutch healthcare system is in transition towards managed competition. In theory, a system of managed competition involves incentives for quality and efficiency of provided care. This is mainly because health insurers contract on behalf of their clients with healthcare providers on, potentially, quality and costs. The paper develops a strategy to comprehensively analyse available multidimensional data on quality and costs to assess and report on the relative performance of healthcare providers within managed competition. Data and methods: We had access to individual information on 2409 clients of 19 Dutch diabetes care groups on a broad range of (outcome and process related) quality and cost indicators. We carried out a cost‐consequences analysis and corrected for differences in case mix to reduce incentives for risk selection by healthcare providers. Results and conclusion: There is substantial heterogeneity between diabetes care groups' performances as measured using multidimensional indicators on quality and costs. Better quality diabetes care can be achieved with lower or higher costs. Routine monitoring using multidimensional data on quality and costs merged at the individual level would allow a systematic and comprehensive analysis of healthcare providers' performances within managed competition. Copyright © 2015 John Wiley & Sons, Ltd. Nutzungsrecht: Copyright © 2015 John Wiley & Sons, Ltd. integrated care health system reform diabetes mellitus type 2 managed competition healthcare providers' performance multidimensional quality costs Competition Health care industry Quality of care Galiën, Onno oth Van den Berg, Bernard oth Enthalten in Health economics Chichester : Wiley-Blackwell, 1992 25(2016), 4, Seite 408-423 (DE-627)170982289 (DE-600)1135838-5 (DE-576)052841952 1057-9230 nnns volume:25 year:2016 number:4 pages:408-423 http://dx.doi.org/10.1002/hec.3158 Volltext http://onlinelibrary.wiley.com/doi/10.1002/hec.3158/abstract http://www.ncbi.nlm.nih.gov/pubmed/25702821 http://search.proquest.com/docview/1769330678 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-WIW SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_26 GBV_ILN_4012 GBV_ILN_4126 GBV_ILN_4219 AR 25 2016 4 408-423
allfieldsGer	10.1002/hec.3158 doi PQ20160610 (DE-627)OLC1975922794 (DE-599)GBVOLC1975922794 (PRQ)p1788-fb911c77b6a1f3707a250c06ad7cbe1c68180c7da9eda1b68900afa50a83266c3 (KEY)0214778520160000025000400408measuringhealthcareprovidersperformanceswithinmana DE-627 ger DE-627 rakwb eng 610 ZDB Portrait, France R. M verfasserin aut Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators 2016 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Background and objectives: The Dutch healthcare system is in transition towards managed competition. In theory, a system of managed competition involves incentives for quality and efficiency of provided care. This is mainly because health insurers contract on behalf of their clients with healthcare providers on, potentially, quality and costs. The paper develops a strategy to comprehensively analyse available multidimensional data on quality and costs to assess and report on the relative performance of healthcare providers within managed competition. Data and methods: We had access to individual information on 2409 clients of 19 Dutch diabetes care groups on a broad range of (outcome and process related) quality and cost indicators. We carried out a cost‐consequences analysis and corrected for differences in case mix to reduce incentives for risk selection by healthcare providers. Results and conclusion: There is substantial heterogeneity between diabetes care groups' performances as measured using multidimensional indicators on quality and costs. Better quality diabetes care can be achieved with lower or higher costs. Routine monitoring using multidimensional data on quality and costs merged at the individual level would allow a systematic and comprehensive analysis of healthcare providers' performances within managed competition. Copyright © 2015 John Wiley & Sons, Ltd. Nutzungsrecht: Copyright © 2015 John Wiley & Sons, Ltd. integrated care health system reform diabetes mellitus type 2 managed competition healthcare providers' performance multidimensional quality costs Competition Health care industry Quality of care Galiën, Onno oth Van den Berg, Bernard oth Enthalten in Health economics Chichester : Wiley-Blackwell, 1992 25(2016), 4, Seite 408-423 (DE-627)170982289 (DE-600)1135838-5 (DE-576)052841952 1057-9230 nnns volume:25 year:2016 number:4 pages:408-423 http://dx.doi.org/10.1002/hec.3158 Volltext http://onlinelibrary.wiley.com/doi/10.1002/hec.3158/abstract http://www.ncbi.nlm.nih.gov/pubmed/25702821 http://search.proquest.com/docview/1769330678 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-WIW SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_26 GBV_ILN_4012 GBV_ILN_4126 GBV_ILN_4219 AR 25 2016 4 408-423
allfieldsSound	10.1002/hec.3158 doi PQ20160610 (DE-627)OLC1975922794 (DE-599)GBVOLC1975922794 (PRQ)p1788-fb911c77b6a1f3707a250c06ad7cbe1c68180c7da9eda1b68900afa50a83266c3 (KEY)0214778520160000025000400408measuringhealthcareprovidersperformanceswithinmana DE-627 ger DE-627 rakwb eng 610 ZDB Portrait, France R. M verfasserin aut Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators 2016 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Background and objectives: The Dutch healthcare system is in transition towards managed competition. In theory, a system of managed competition involves incentives for quality and efficiency of provided care. This is mainly because health insurers contract on behalf of their clients with healthcare providers on, potentially, quality and costs. The paper develops a strategy to comprehensively analyse available multidimensional data on quality and costs to assess and report on the relative performance of healthcare providers within managed competition. Data and methods: We had access to individual information on 2409 clients of 19 Dutch diabetes care groups on a broad range of (outcome and process related) quality and cost indicators. We carried out a cost‐consequences analysis and corrected for differences in case mix to reduce incentives for risk selection by healthcare providers. Results and conclusion: There is substantial heterogeneity between diabetes care groups' performances as measured using multidimensional indicators on quality and costs. Better quality diabetes care can be achieved with lower or higher costs. Routine monitoring using multidimensional data on quality and costs merged at the individual level would allow a systematic and comprehensive analysis of healthcare providers' performances within managed competition. Copyright © 2015 John Wiley & Sons, Ltd. Nutzungsrecht: Copyright © 2015 John Wiley & Sons, Ltd. integrated care health system reform diabetes mellitus type 2 managed competition healthcare providers' performance multidimensional quality costs Competition Health care industry Quality of care Galiën, Onno oth Van den Berg, Bernard oth Enthalten in Health economics Chichester : Wiley-Blackwell, 1992 25(2016), 4, Seite 408-423 (DE-627)170982289 (DE-600)1135838-5 (DE-576)052841952 1057-9230 nnns volume:25 year:2016 number:4 pages:408-423 http://dx.doi.org/10.1002/hec.3158 Volltext http://onlinelibrary.wiley.com/doi/10.1002/hec.3158/abstract http://www.ncbi.nlm.nih.gov/pubmed/25702821 http://search.proquest.com/docview/1769330678 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-WIW SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_26 GBV_ILN_4012 GBV_ILN_4126 GBV_ILN_4219 AR 25 2016 4 408-423
language	English
source	Enthalten in Health economics 25(2016), 4, Seite 408-423 volume:25 year:2016 number:4 pages:408-423
sourceStr	Enthalten in Health economics 25(2016), 4, Seite 408-423 volume:25 year:2016 number:4 pages:408-423
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	integrated care health system reform diabetes mellitus type 2 managed competition healthcare providers' performance multidimensional quality costs Competition Health care industry Quality of care
dewey-raw	610
isfreeaccess_bool	false
container_title	Health economics
authorswithroles_txt_mv	Portrait, France R. M @@aut@@ Galiën, Onno @@oth@@ Van den Berg, Bernard @@oth@@
publishDateDaySort_date	2016-01-01T00:00:00Z
hierarchy_top_id	170982289
dewey-sort	3610
id	OLC1975922794
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1975922794</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230714193153.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">160609s2016 xx \|\|\|\|\| 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/hec.3158</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20160610</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1975922794</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1975922794</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)p1788-fb911c77b6a1f3707a250c06ad7cbe1c68180c7da9eda1b68900afa50a83266c3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0214778520160000025000400408measuringhealthcareprovidersperformanceswithinmana</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ZDB</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Portrait, France R. M</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background and objectives: The Dutch healthcare system is in transition towards managed competition. In theory, a system of managed competition involves incentives for quality and efficiency of provided care. This is mainly because health insurers contract on behalf of their clients with healthcare providers on, potentially, quality and costs. The paper develops a strategy to comprehensively analyse available multidimensional data on quality and costs to assess and report on the relative performance of healthcare providers within managed competition. Data and methods: We had access to individual information on 2409 clients of 19 Dutch diabetes care groups on a broad range of (outcome and process related) quality and cost indicators. We carried out a cost‐consequences analysis and corrected for differences in case mix to reduce incentives for risk selection by healthcare providers. Results and conclusion: There is substantial heterogeneity between diabetes care groups' performances as measured using multidimensional indicators on quality and costs. Better quality diabetes care can be achieved with lower or higher costs. Routine monitoring using multidimensional data on quality and costs merged at the individual level would allow a systematic and comprehensive analysis of healthcare providers' performances within managed competition. Copyright © 2015 John Wiley & Sons, Ltd.</subfield></datafield><datafield tag="540" ind1=" " ind2=" "><subfield code="a">Nutzungsrecht: Copyright © 2015 John Wiley & Sons, Ltd.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">integrated care</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">health system reform</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">diabetes mellitus type 2</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">managed competition</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">healthcare providers' performance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">multidimensional quality</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">costs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Competition</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health care industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Quality of care</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Galiën, Onno</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Van den Berg, Bernard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Health economics</subfield><subfield code="d">Chichester : Wiley-Blackwell, 1992</subfield><subfield code="g">25(2016), 4, Seite 408-423</subfield><subfield code="w">(DE-627)170982289</subfield><subfield code="w">(DE-600)1135838-5</subfield><subfield code="w">(DE-576)052841952</subfield><subfield code="x">1057-9230</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:408-423</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://dx.doi.org/10.1002/hec.3158</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://onlinelibrary.wiley.com/doi/10.1002/hec.3158/abstract</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://www.ncbi.nlm.nih.gov/pubmed/25702821</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://search.proquest.com/docview/1769330678</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-WIW</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_26</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4219</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2016</subfield><subfield code="e">4</subfield><subfield code="h">408-423</subfield></datafield></record></collection>
author	Portrait, France R. M
spellingShingle	Portrait, France R. M ddc 610 misc integrated care misc health system reform misc diabetes mellitus type 2 misc managed competition misc healthcare providers' performance misc multidimensional quality misc costs misc Competition misc Health care industry misc Quality of care Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators
authorStr	Portrait, France R. M
ppnlink_with_tag_str_mv	@@773@@(DE-627)170982289
format	Article
dewey-ones	610 - Medicine & health
delete_txt_mv	keep
author_role	aut
collection	OLC
remote_str	false
illustrated	Not Illustrated
issn	1057-9230
topic_title	610 ZDB Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators integrated care health system reform diabetes mellitus type 2 managed competition healthcare providers' performance multidimensional quality costs Competition Health care industry Quality of care
topic	ddc 610 misc integrated care misc health system reform misc diabetes mellitus type 2 misc managed competition misc healthcare providers' performance misc multidimensional quality misc costs misc Competition misc Health care industry misc Quality of care
topic_unstemmed	ddc 610 misc integrated care misc health system reform misc diabetes mellitus type 2 misc managed competition misc healthcare providers' performance misc multidimensional quality misc costs misc Competition misc Health care industry misc Quality of care
topic_browse	ddc 610 misc integrated care misc health system reform misc diabetes mellitus type 2 misc managed competition misc healthcare providers' performance misc multidimensional quality misc costs misc Competition misc Health care industry misc Quality of care
format_facet	Aufsätze Gedruckte Aufsätze
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	nc
author2_variant	o g og d b b v dbb dbbv
hierarchy_parent_title	Health economics
hierarchy_parent_id	170982289
dewey-tens	610 - Medicine & health
hierarchy_top_title	Health economics
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)170982289 (DE-600)1135838-5 (DE-576)052841952
title	Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators
ctrlnum	(DE-627)OLC1975922794 (DE-599)GBVOLC1975922794 (PRQ)p1788-fb911c77b6a1f3707a250c06ad7cbe1c68180c7da9eda1b68900afa50a83266c3 (KEY)0214778520160000025000400408measuringhealthcareprovidersperformanceswithinmana
title_full	Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators
author_sort	Portrait, France R. M
journal	Health economics
journalStr	Health economics
lang_code	eng
isOA_bool	false
dewey-hundreds	600 - Technology
recordtype	marc
publishDateSort	2016
contenttype_str_mv	txt
container_start_page	408
author_browse	Portrait, France R. M
container_volume	25
class	610 ZDB
format_se	Aufsätze
author-letter	Portrait, France R. M
doi_str_mv	10.1002/hec.3158
dewey-full	610
title_sort	measuring healthcare providers' performances within managed competition using multidimensional quality and cost indicators
title_auth	Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators
abstract	Background and objectives: The Dutch healthcare system is in transition towards managed competition. In theory, a system of managed competition involves incentives for quality and efficiency of provided care. This is mainly because health insurers contract on behalf of their clients with healthcare providers on, potentially, quality and costs. The paper develops a strategy to comprehensively analyse available multidimensional data on quality and costs to assess and report on the relative performance of healthcare providers within managed competition. Data and methods: We had access to individual information on 2409 clients of 19 Dutch diabetes care groups on a broad range of (outcome and process related) quality and cost indicators. We carried out a cost‐consequences analysis and corrected for differences in case mix to reduce incentives for risk selection by healthcare providers. Results and conclusion: There is substantial heterogeneity between diabetes care groups' performances as measured using multidimensional indicators on quality and costs. Better quality diabetes care can be achieved with lower or higher costs. Routine monitoring using multidimensional data on quality and costs merged at the individual level would allow a systematic and comprehensive analysis of healthcare providers' performances within managed competition. Copyright © 2015 John Wiley & Sons, Ltd.
abstractGer	Background and objectives: The Dutch healthcare system is in transition towards managed competition. In theory, a system of managed competition involves incentives for quality and efficiency of provided care. This is mainly because health insurers contract on behalf of their clients with healthcare providers on, potentially, quality and costs. The paper develops a strategy to comprehensively analyse available multidimensional data on quality and costs to assess and report on the relative performance of healthcare providers within managed competition. Data and methods: We had access to individual information on 2409 clients of 19 Dutch diabetes care groups on a broad range of (outcome and process related) quality and cost indicators. We carried out a cost‐consequences analysis and corrected for differences in case mix to reduce incentives for risk selection by healthcare providers. Results and conclusion: There is substantial heterogeneity between diabetes care groups' performances as measured using multidimensional indicators on quality and costs. Better quality diabetes care can be achieved with lower or higher costs. Routine monitoring using multidimensional data on quality and costs merged at the individual level would allow a systematic and comprehensive analysis of healthcare providers' performances within managed competition. Copyright © 2015 John Wiley & Sons, Ltd.
abstract_unstemmed	Background and objectives: The Dutch healthcare system is in transition towards managed competition. In theory, a system of managed competition involves incentives for quality and efficiency of provided care. This is mainly because health insurers contract on behalf of their clients with healthcare providers on, potentially, quality and costs. The paper develops a strategy to comprehensively analyse available multidimensional data on quality and costs to assess and report on the relative performance of healthcare providers within managed competition. Data and methods: We had access to individual information on 2409 clients of 19 Dutch diabetes care groups on a broad range of (outcome and process related) quality and cost indicators. We carried out a cost‐consequences analysis and corrected for differences in case mix to reduce incentives for risk selection by healthcare providers. Results and conclusion: There is substantial heterogeneity between diabetes care groups' performances as measured using multidimensional indicators on quality and costs. Better quality diabetes care can be achieved with lower or higher costs. Routine monitoring using multidimensional data on quality and costs merged at the individual level would allow a systematic and comprehensive analysis of healthcare providers' performances within managed competition. Copyright © 2015 John Wiley & Sons, Ltd.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-WIW SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_26 GBV_ILN_4012 GBV_ILN_4126 GBV_ILN_4219
container_issue	4
title_short	Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators
url	http://dx.doi.org/10.1002/hec.3158 http://onlinelibrary.wiley.com/doi/10.1002/hec.3158/abstract http://www.ncbi.nlm.nih.gov/pubmed/25702821 http://search.proquest.com/docview/1769330678
remote_bool	false
author2	Galiën, Onno Van den Berg, Bernard
author2Str	Galiën, Onno Van den Berg, Bernard
ppnlink	170982289
mediatype_str_mv	n
isOA_txt	false
hochschulschrift_bool	false
author2_role	oth oth
doi_str	10.1002/hec.3158
up_date	2024-07-03T14:03:58.624Z
_version_	1803566908572696576
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1975922794</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230714193153.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">160609s2016 xx \|\|\|\|\| 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/hec.3158</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20160610</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1975922794</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1975922794</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)p1788-fb911c77b6a1f3707a250c06ad7cbe1c68180c7da9eda1b68900afa50a83266c3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0214778520160000025000400408measuringhealthcareprovidersperformanceswithinmana</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ZDB</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Portrait, France R. M</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background and objectives: The Dutch healthcare system is in transition towards managed competition. In theory, a system of managed competition involves incentives for quality and efficiency of provided care. This is mainly because health insurers contract on behalf of their clients with healthcare providers on, potentially, quality and costs. The paper develops a strategy to comprehensively analyse available multidimensional data on quality and costs to assess and report on the relative performance of healthcare providers within managed competition. Data and methods: We had access to individual information on 2409 clients of 19 Dutch diabetes care groups on a broad range of (outcome and process related) quality and cost indicators. We carried out a cost‐consequences analysis and corrected for differences in case mix to reduce incentives for risk selection by healthcare providers. Results and conclusion: There is substantial heterogeneity between diabetes care groups' performances as measured using multidimensional indicators on quality and costs. Better quality diabetes care can be achieved with lower or higher costs. Routine monitoring using multidimensional data on quality and costs merged at the individual level would allow a systematic and comprehensive analysis of healthcare providers' performances within managed competition. Copyright © 2015 John Wiley & Sons, Ltd.</subfield></datafield><datafield tag="540" ind1=" " ind2=" "><subfield code="a">Nutzungsrecht: Copyright © 2015 John Wiley & Sons, Ltd.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">integrated care</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">health system reform</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">diabetes mellitus type 2</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">managed competition</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">healthcare providers' performance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">multidimensional quality</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">costs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Competition</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health care industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Quality of care</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Galiën, Onno</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Van den Berg, Bernard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Health economics</subfield><subfield code="d">Chichester : Wiley-Blackwell, 1992</subfield><subfield code="g">25(2016), 4, Seite 408-423</subfield><subfield code="w">(DE-627)170982289</subfield><subfield code="w">(DE-600)1135838-5</subfield><subfield code="w">(DE-576)052841952</subfield><subfield code="x">1057-9230</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:408-423</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://dx.doi.org/10.1002/hec.3158</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://onlinelibrary.wiley.com/doi/10.1002/hec.3158/abstract</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://www.ncbi.nlm.nih.gov/pubmed/25702821</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://search.proquest.com/docview/1769330678</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-WIW</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_26</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4219</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2016</subfield><subfield code="e">4</subfield><subfield code="h">408-423</subfield></datafield></record></collection>
score	7.396736

Nicht das Richtige dabei?

Schreiben Sie uns!

Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?